Abstract��Chondroitin sulfate (CS) is an anionic linear polysaccharide having natural bioactivity, which is widely utilized as a drug and nutraceutical . Due to the structure complexity and source variety of chondroitin sulfate, the specifications of chondroitin sulfate in different pharmacopoeias were different. The related references published in recent years and pharmacopeias were analyzed, sorted, and summarized. This review summarized the METHODS and limits that were used to for the assay and inspection of impurities, disaccharide and relative molecular weight of chondroitin sulfate. This article would be beneficial to improve the quality control system of chondroitin sulfate.
������, ����Ƽ, ���ۺ�. ������������������о���չ[J]. �й�ҩѧ��־, 2016, 51(12): 962-966.
HOU Mei-man, REN Li-ping, FAN Hui-hong. Overview of the Quality Control of Chondroitin Sulfate. Chinese Pharmaceutical Journal, 2016, 51(12): 962-966.
REJHOLEC V. Long term studies of antiosteoarthritic drugs:an assessment[J]. Semin Arthritis Rheum, 1987, 17(2 suppl 1):35-53.
[2]
RONCA F, PALMIERI L, PANICUCCI P, et al. Anti-inflammatory activity of chondroitin sulfate[J]. Osteoarthritis Cartilage, 1998, 6(suppl A):14-21.
[3]
HUSKISSON E C. Glucosamine and chondroitin for osteoarthritis[J]. J Int Med Res, 2008, 36(6):1161-1179.
[4]
VOLPI N. The pathobiology of osteoarthritis and the rationale for using chondroitin sulfate for its treatment[J]. Curr Drug Targets Immune Endocr Metabol Disord, 2004, 4(2):119-127.
[5]
VOLPI N. Therapeutic applications of glycosaminoglycans[J]. Curr Med Chem, 2006, 13(15):1799-1810.
[6]
SARZI-PUTTINI P, CIMMINO M A, SCARPA R, et al. Osteoarthritis:an overview of the disease and its treatment strategies[J]. Semin Arthritis Rheum, 2005, 35(1 suppl 1):1-10.
[7]
ZHANG T M, LIN P X. Recent advances in glycosaminoglycan[J]. Food Drug(ʳƷ��ҩƷ), 2008, 10(9):1-5.
[8]
VOLPI N. Quality of different chondroitin sulfate preparations in relation to their therapeutic activity[J]. J Pharm Pharm, 2009, 61(10):1271-1280.
[9]
UEBELHART D, KNOLS R, DE BRUIN E D, et al. Treatment of knee osteoarthritis with oral chondroitin sulfate[J]. Adv Pharm, 2006, 53:475-488.
[10]
KAHAN A, UEBELHART D, DE VATHAIRE F, et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis:the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial[J]. Arthritis Rheum, 2009, 60(2):524-533.
[11]
LIU Y, HE T, GAO C. Surface modification of poly(ethylene terephthalate)via hydrolysis and layer-by-layer assembly of chitosan and chondroitin sulfate to construct cytocompatible layer for human endothelial cells[J]. Colloids Surf B Biointerfaces, 2005, 46(2) :117-126.
[12]
YANG S H, CHEN P Q, CHEN Y F, et al. An in vitro study on regeneration of human nucleus pulposus by using gelatin/chondroitin-6-sulfate/hyaluronan tri-copolymer scaffold[J]. Artif Organs, 2005, 29(10):806-814.
[13]
LIU L R, ZHANG S H, MA D R, er al. Construction of artificial dermis on collagen chondroitin sulfate scaffold crosslinked by 1-ethyl-3-(13dimethyl aminopropyl)carbodiimide [J]. Chin J Repar Reconstr Surg(�й����ؽ������־), 2003, 17(2):83-88.
[14]
SHEN B J, DOU Y. The application of chondroitin sulfate products in Australia [J]. Food Drug(ʳƷ��ҩƷ), 2009, 11(1):4-7.
[15]
LAUDER R M, HUCKERBY T N, NIEDUSZYNSKI I A. A fingerprinting method for chondroitin/dermatan sulfate and hyaluronan oligosaccharides[J]. Glycobiology, 2000, 10(4):393-401.
[16]
LAUDER R M, HUCKERBY T N, BROWN G M, et al. Age-related changes in the sulphation of the chondroitin sulphate linkage region from human articular cartilage aggrecan[J]. Biochem J, 2001, 358(2):523-528.
[17]
BAYLISS M T, OSBORNE D, WOODHOUSE S, et al. Sulfation of chondroitin sulfate in human articular cartilage. The effect of age, topographical position and zone of cartilage on tissue composition[J]. J Biol Chem, 1999, 274(2):15892-15900.
[18]
LAUDER R M. Chondroitin sulphate:a complex molecule with potential impacts on a wide range of biological systems[J]. Complemen Ther Med, 2009, 17(1):56-62.
[19]
GAMA C I, TULLY S E, SOTOGAKU N, et al. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity[J]. Nat Chem Biol, 2006, 2(9):467-473.
[20]
DICK G, TAN C L, ALVES J N, et al. Semaphorin 3A binds to the perineuronal nets via chondroitin sulfate type E motifs in rodent brains[J]. J Biol Chem, 2013, 288(38):27384-27395.
VOLPI N. Analytical aspects of pharmaceutical grade chondroitin sulfates[J]. J Pharm Sci, 2007, 96(12):3168-3180.
[25]
VOLPI N. Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine[J]. Anal Biochem, 2000, 277(1):19-24.
[26]
MACCARI F, VOLPI N. Direct and specific recognition of glycosaminoglycans by antibodies after their separation by agarose-gel electrophoresis and blotting on cetylpyridinium chloride-tre-ated nitrocellulose membranes[J]. Electrophoresis, 2003, 24(9):1347-1352.
[27]
VOLPI N. Disaccharide mapping of chondroitin sulfate of different origins by high-performance capillary electrophoresis and high-performance liquid chromatography[J]. Carbohydr Polym, 2004, 55(3):273-281.
[28]
GUO S L, ZHANG Y. Research progress in the determination of chondroitin sulfate[J]. Meat Ind(���ҵ), 2012, (6):49-52.
[29]
JIANG Y H, ZHANG Y. Official methods for determination of chondroitin sulfate[J]. Food Drug(ʳƷ��ҩƷ), 2009, 11(2):68-70.
[30]
ZHANG T M, LIN P X. Chondroitin sulfate:history, current status and future trends[J]. Food Drug(ʳƷ��ҩƷ), 2010, 12(1):1-3.
[31]
YU H Z, FAN H H, SONG Y J, et al. Research advances in the determination of chondroitin sulfate[J]. Chin J Biochem Pharm ( �й�����ҩ����־), 2011, 32(2):160-162.
[32]
KAROUSOU E G, VIOLA M, GENASETTI A, et al. Application of polyacrylamide gel electrophoresis of fluorophore-labeled saccharides for analysis of hyaluronan and chondroitin sulfate in human and animal tissues and cell cultures[J]. Biomed Chromatogr, 2005, 19(10):761-765.
[33]
MURATA K, YOKOYAMA Y. A high-performance liquid chromatography for constituent disaccharides of chondroitin sulfate and dermatan sulfate isomers[J]. Anall Biochem, 1985, 146(2):327-335.
[34]
LI T, OKUDA S, HIRANO T, et al. Tandem mass spectrometry for characterization of unsaturated disaccharides from chondroitin sulfate, dermatan sulfate and hyaluronan[J]. Glycoconj J, 1994, 11(2):123-132.
[35]
DESAIRE H, LEARY J A. Detection and quantification of the sulfated disaccharides in chondroitin sulfate by electrospray tandem mass spectrometry[J]. J Am Soc Mass Spectrom, 2000, 11(10):916-920.
[36]
VANESSA L G, UDAYANATH A, SRINIVASA R, et al. Disaccharide analysis of glycosaminoglycans using hydrophilic interaction chromatography and mass spectrometry [J]. J Am Soc Mass Spectrom, 2013, 85(2):1138-1145.
[37]
National Drug Standards(2002) Vol IX(����ҩƷ�� ��ѧҩƷ�ط����������ұ��ھŲ�) [S]. 2002:9-294-9-295.
[38]
LI J, FAN H H, XU K S. Study on the current status and the quality standard of low-molecular-weight heparin[J]. Chin J Biochem Pharm (�й�����ҩ����־), 2004, 25(1):53-55.
[39]
SONG Y J, REN L P, FAN H H. Determination of molecular weight and its distribution of chondroitin sulfate sodium[J]. Chin New Drug J(�й���ҩ��־), 2011, 24(18):1795-1797.
[40]
DANIA B, FRANCESCA M, NICOLA V. Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE) [J]. J Pharm Biomed Anal, 2010, 51(4):969-972.
2016, Vol. 51 
